spa718

aphcon tmg btg aubho2015 btg2015 aubho2014 the medal group aml leukemia multiple myeloma stem cell transplantation thalassemia acute myeloid leukemia cell therapy nilotinib dasatinib chronic myelogenous leukemia imatinib breast cancer lung cancer myelofibrosis cml colon cancer haploidentical donor all aplastic anemia hodgkins lymphoma acute lymphocytic leuekmia cytogenetic analysis in hematological malignancies targeted therapy for hodgkin’s lymphoma pancreatic cancer lymphoma double hit and other molecularly defined large cel aphcon. primary cns lymphoma: focus on role of radiation acute lymphocytic leukemia hpv cholangiocarcinoma radiation common pitfalls in bone marrow biopsy based diagno allogeneic stem cell transplant tki acute promyelocytic leukemia breakthroughs in the treatment of acute promyelocy fungal infections in hematology patients: advances smoldering myeloma treatment advances in immunotherapy for lymphomas and myelom tregs gvhd oligoblastic aml inhibitors in congenital hemophilia challenges in rx hemophilia-2 mupinase communication to s ms multicenter phase 3 study comparing carfilzomib mantle cell lymphoma: from bench to clinic optimizing timing of transplant in hodgkin lympho hodgkin lymphoma: latest concepts upfront transplant strategies in aplastic anemia new strategies for the prevention and treatment of present and future donor lymphocyte infusion in patients with hematol cellular immune therapy with allogeneic stem cell starting therapy for low risk myeloma fish in myeloma maintenance therapy in multiple myeloma slides supportive final- tgm hematopoietic stem cell transplantation: high risk molecular markers in nktl flt3 inhibitors minimal residual disease in aml therapy for relapsed multiple myeloma relapse myeloma relapsed myeloma robert orlowski ravi vij jak2 inhibitor serge verstovsek elias jabbour qian jiang marcos delima mohamad mohty steve kornblau jian xian wang mds all in children upfront transplant in all-hl acute lymphoblastic leukaemia (all) in children philadephia chromosomal positive acute lymphoblast serum free light chain assay multiple myeloma risk stratification hong kong case studies diagnostic and treatment dilemmas in nhl=part 2 diagnostic and treatment dilemmas in nhl follicular lymphoma; updates on treatment strateg treatment of non-hidgkin's lymphoma in elderly pat switching of tki in cml cml-case based discussion side effects of tkis monitoring of minimal residual disease principles molecular monitoring subhash varma hematologic malignancies donor lymphocyte infusion myelodysplastic syndrome transplant cord blood donor cord blood transplant unrelated donor donor selection chelation sibling donor transplant tbtg2015 donor seletion stem cell transplant nina shah jin lu car-t cell adipocytes bone marrow itp dengue hemorrhagic fever autologous stem cell transplant eldery mdacc gap nhl regulatory t cells auhbo2015 liver cancer surgery rectal cancer hepatobiliary cancer and dexamethasone (crd) vs lenalidomide and dexame a randomized lenalidomide changing landscape of treatment for multiple myelo recent advances in the development of innovative application of fish in hematologic malignancies approach to young high risk aml patients with limited resources neutropenic fever: challenges and treatment “pearls” for getting published in a peer revie pearls to get your grants funded neutropenic fever : challenges and treatment healthcare it platform houston sln cranial irradiation small cell lung cancer gynecologocical cancers chemotherapy head and neck cancers oropharyngeal cancer laryngeal cancer oropharyngeal cancers gi cancer t cell lymphoma high risk lymphoma newly diagnosed myeloma immunotherapy elderly aml ap cellular therapy nk cell